Diagnosis:
Neurodegenerative disease, protein aggregations
• Protein aggregation is a common finding in neurodegenerative diseases and can help classified diseases according to the protein that accumulates in different groups,such as Alzheimer disease, prion disease, tauopathies, and α-synucleoplathies. Aggregation of proteins can be the result of protein misfolding, in the case of tau accompanied by hyperphosphorylation.
• In Alzheimer disease, β Amyloid deposits form extracellular aggregates called amyloid plaques.
• Tauopathies, such as progressive supranuclear palsy, corticobasal degeneration, and frontotemporal lobe dementia, share with Alzheimer disease the presence of cytoplasmic, fibrillar aggregates of tau protein termed neurofibrillary tangles.
• In Pick disease, a tauopathy, basophilic, round and well-demarcated cytoplasmic inclusions are seen and are called Pick bodies. These inclusions also stain with the antitau antibodies that react with neurofibrillary tangles.
• Parkinson disease (PD) and dementia with Lewy bodies reveal cytoplasmic accumulations of α-synuclein called Lewy bodies. In multiple system atrophy, cytoplasmic inclusions positive for α-synuclein are seen predominantly in oligodendrocytes and are called glial cytoplasmic inclusions.
• In prion diseases, misfolded and aggregated versions of the normal cellular prion protein (PrP) are identified.
Dickson DW, Weller RO (eds): Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, 2nd ed. Oxford, country-regionUK: Wiley-Blackwell: International Society of Neuropathology, 2011.
Ellison D, Love S, Chimelli L, et al (eds): Neuropathology: A Reference Text of CNS Pathology, 3rd ed. Edinburgh: Mosby Elsevier, 2013.